Common blood tests before cancer diagnosis and implications for primary care
BJGP Interviews · The British Journal of General Practice
Audio is streamed directly from the publisher (podcasts.captivate.fm) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
In this episode, we talk to Ben Cranfield, who is undertaking a PhD In the Department of Behavioural Science and Health at UCL.
Paper: Primary care blood tests before cancer diagnosis: National Cancer Diagnosis audit data
Available at: https://doi.org/10.3399/BJGP.2022.0265
Evidence relating to the predictive value of blood tests for cancer diagnosis is growing, yet how often they are used by GPs in pre-diagnosed cancer patients is unclear. In England, two-fifths of patients subsequently diagnosed with cancer in 2018 had at least one full blood count, urea & electrolyte or liver function test. Blood test use was less likely in women, non-white and younger patients and more likely in those presenting with non-specific symptoms, with longer intervals to referral and diagnosis being associated with tested patients. This research highlights potential unmet need for interventions to reduce the risk of overuse (in populations presenting with more-specific symptoms) and underuse (in patients presenting with less-specific symptoms) of blood tests in cancer populations.